Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this research study is to evaluate the best way to manage breakthrough spotting and bleeding during an extended use regimen of NuvaRing®. Ease of use and acceptability of a flexible regimen of NuvaRing® will also be evaluated. A comparison of cyclic mood symptoms, pelvic pain, and headaches will be made between a standard 21/7 regimen and an extended regimen.
Epistemonikos ID: bca1a32199cde7783b9ba2fe5cd618dc06c96796
First added on: May 04, 2024